Trial intelligence / Profile preview

Use of Hyperpolarized 129 Xe MR Lung Imaging in Children and Adults

NCT02272049Phase 2Recruiting

Sponsor
Cincinnati Children's Hospital Medical Center
Start
Dec 2014
Primary completion
Dec 2028
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of hyperpolarized xenon gas in Respiratory and pulmonary disorders, sponsored by Cincinnati Children's Hospital Medical Center. Started Dec 2014; status: recruiting.

02

Drugs

hyperpolarized xenon gas
03

Conditions

Respiratory and pulmonary disorders

Beyond the preview

Go deeper on NCT02272049.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02272049.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call